InvestorsHub Logo
Followers 8
Posts 921
Boards Moderated 0
Alias Born 10/07/2015

Re: FLY HIGH NOW post# 5964

Sunday, 10/22/2017 1:18:39 AM

Sunday, October 22, 2017 1:18:39 AM

Post# of 6070
we need higher revenues through market expansion

https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-238-million-registered-direct-offering-led-by-existing-shareholders-300536401.html

I am not sure which website is correct on the timeline: 4-6 weeks or months but probably the latter?

http://stocknewsunion.com/8476-2/8476/
"agency is also reviewing an application for approval of MARQIBO for the treatment of adult patients with Philadelphia chromosome negative lymphoblastic leukemia. A review of the drug is set to be complete in the next four to six weeks."


https://seekingalpha.com/news/3294112-casi-provides-pipeline-development-update

The CFDA review of MARQIBO and CTA is in process. Its review is expected to complete in the next four to six months and confirmatory trial will initiate within six months after CTA approval.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.